Clinical features of Alzheimer’s disease

  title={Clinical features of Alzheimer’s disease},
  author={Hans F{\"o}rstl and Alexander Kurz},
  journal={European Archives of Psychiatry and Clinical Neuroscience},
  • Hans Förstl, A. Kurz
  • Published 1999
  • Psychology, Medicine
  • European Archives of Psychiatry and Clinical Neuroscience
Abstract The preclinical stage of Alzheimer’s disease is inconspicuous and there are – almost by definition – no reliable and valid symptoms and signs which would allow a very early diagnosis before the manifestation of irreversible deficits. For a clinical diagnosis of dementia, cognitive impairment has to be severe enough to compromise the activities of daily living. In the mild dementia stage, difficulties with declarative memory are usually prominent; depressive symptoms are not infrequent… 
Diagnosis of Alzheimer’s Disease with [18F]PET in Mild and Asymptomatic Stages
  • A. Drzezga
  • Psychology, Biology
    Behavioural neurology
  • 2009
The purpose of this article is to describe the typical findings of [18F]FDG PET in different stages of AD and to demonstrate its value for early and reliable diagnosis of Alzheimer's disease, particularly ahead of the stage of dementia of the Alzheimer’s type.
Neuroimaging biomarkers in Alzheimer’s disease
Analysis of EEG Signals for Diagnosis of Alzheimer Disease
A review of previous paper has been put up and some of the problem has been found out during the diagnosing AD from EEG, to improve the accuracy for the diagnosis of the EEG signal.
Alzheimer’s disease: Causes & treatment – A review
There are no disease-modifying drugs available for Alzheimer’s disease but some options may reduce its symptoms and help improve quality of life and thereby help the patients to some extent.
Amyloid-Plaque Imaging in Diagnosis of Dementia
Modern molecular imaging tracers such as Positron Emission Tomography (PET) allow the characterization of dementing disorders on the basis of the underlying pathology rather than on their symptomatic appearance, and may offer improved options for early and differential diagnosis, as well as for patient selection for therapy trials and for objective therapy monitoring.
Diagnosis of Alzheimer Disease using EEG Signals
The need is to improve the diagnosis accuracy of the EEG signal by using various methods to develop the detection of the disease in early stage called as Dementia, the first stage called Mild cognitive impairment (MCI).
Amyloid-plaque imaging in early and differential diagnosis of dementia
  • A. Drzezga
  • Biology, Medicine
    Annals of nuclear medicine
  • 2010
The options of amyloid-plaque imaging regarding early and differential diagnosis of different forms of dementia as well as for patient selection for therapy trials and for objective therapy monitoring are discussed.
Early diagnosis of Alzheimer's disease with cognitive neuropsychological tests
The present and future researches of early diagnosis method through cognitive and functional imaging testing to help with the clinical diagnosis are described.
Alzheimer’s Disease: A Major Health Problem of Elderly People
  • Medicine
  • 2019
A brief introduction to Alzheimer's disease and the related concept of dementia and mild cognitive impairment (MCI) is provided and the other main aspects of AD including risk factors are demonstrated.


The neurologic syndrome of severe Alzheimer's disease. Relationship to functional decline.
Prevalence and mean scores of certain release signs, certain extrapyramidal measures commonly referred to as bradykinesia, and certain pyramidal signs showed significant associations with the magnitude of functional impairment.
Behavioral Disturbances of Dementia: An Overview of Phenomenology and Methodologic Concerns
Using rating scales that have been developed from publications in the late 1980s will enable clinicians to assess pharmacological and nonpharmacological intervention strategies for behavioral symptoms in dementia with enhanced sensitivity.
Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerized tomography findings
Thirty‐one of 50 patients satisfying the NINCDS‐ADRDA criteria of probable or possible Alzheimer's disease showed psychotic features during a 2‐year observation period, which may indicate that specific psychotic features and their potential organic substrate exert an effect on the progression of illness and on survival in Alzheimer's Disease.
Advanced Alzheimer's disease is a risk factor for late-onset seizures.
It is concluded that advanced Alzheimer's disease alone may be an important risk factor for new-onset seizures in older adults.
Early‐onset Alzheimer's disease
The age of the patients had a significant modifying effect on these predictive factors, resulting in a greater risk of institutionalization and death in younger patients with severe cognitive impairment as compared with older individuals with the same degree of dysfunction.
Psychopathologische Störungen bei beginnender Alzheimerscher Krankheit
The investigation of patients with Alzheimer's disease was based on the following questions: which symptoms occur at onset, which cognitive, non cognitive and neurological symptoms already appear in
The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort.
Findings support previous contentions that a "preclinical phase" of detectable cognitive deficits can precede the clinical diagnosis of probable AD by many years, and support the hypothesis that problems with secondary verbal memory are among the first signs of AD.
Neurological signs in Alzheimer's disease.
Neurological signs were assessed in 178 patients satisfying NINCDS/ADRDA criteria for Alzheimer's disease and a grasp reflex, extrapyramidal signs and symptoms were associated with severe cognitive impairment.
Cognitive test performance in detecting, staging, and tracking Alzheimer's disease.
It is postulated that the pathologic bases of impairment in delayed recall are atrophy of cholinergic ventral forebrain neurons and partial deafferentation of the hippocampus, both of which occur early in the course of AD.
Patterns of motor impairement in normal aging, mild cognitive decline, and early Alzheimer's disease.
Results indicate that motor impairment is an important aspect of cognitive decline in older adults and motor/psychomotor assessments may be comparably sensitive to traditional tests of cognitive function in identifying persons affected by the earliest stages of AD pathology.